Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
{{output}}
Background: Mepolizumab is a humanized monoclonal antibody that targets interleukin-5, a cytokine that plays a central role in eosinophilic inflammation, which is present in 20 to 40% of patients with chronic obstructive pulmonar... ...
